Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Clinical trial NCT00843882 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00843882
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-29
- Primary completion
- 2019-07-08
- Enrollment
- 247
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.